D.E. Shaw & Co’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12K Hold
74,822
﹤0.01% 4464
2025
Q4
$1.94K Hold
74,822
﹤0.01% 4543
2025
Q3
$1.53K Hold
74,822
﹤0.01% 4499
2025
Q2
$995 Hold
74,822
﹤0.01% 4299
2025
Q1
$3.59K Hold
74,822
﹤0.01% 4168
2024
Q4
$5.99K Hold
74,822
﹤0.01% 4298
2024
Q3
$2.92K Hold
74,822
﹤0.01% 4455
2024
Q2
$2.99K Hold
74,822
﹤0.01% 4389
2024
Q1
$7.11K Hold
74,822
﹤0.01% 4195
2023
Q4
$13K Hold
74,822
﹤0.01% 4097
2023
Q3
$2.62K Hold
74,822
﹤0.01% 4181
2023
Q2
$9.5K Hold
74,822
﹤0.01% 4055
2023
Q1
$25.1K Hold
74,822
﹤0.01% 4117
2022
Q4
$3.7K Hold
74,822
﹤0.01% 4720
2022
Q3
$9K Hold
74,822
﹤0.01% 4952
2022
Q2
$8K Hold
74,822
﹤0.01% 5170
2022
Q1
$15K Buy
+74,822
New +$17.8K ﹤0.01% 5371

Other funds holding CDIOW

D.E. Shaw & Co's CDIOW Position: Q1 2026 in Review

D.E. Shaw & Co held its Cardio Diagnostics Holdings Inc Warrant (CDIOW) position steady in Q1 2026 at 74,822 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #4464.

D.E. Shaw & Co first reported a position in CDIOW in Q1 2022 and has held it in 17 quarters since. The position peaked at $25.1K in Q1 2023. 7 funds tracked by Wall St. Rank hold CDIOW as of Q1 2026.

  • D.E. Shaw & Co held 74,822 shares of Cardio Diagnostics Holdings Inc Warrant worth $1.12K as of Q1 2026.
  • D.E. Shaw & Co left its Cardio Diagnostics Holdings Inc Warrant share count unchanged in Q1 2026.
  • Cardio Diagnostics Holdings Inc Warrant made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4464 holding.
  • D.E. Shaw & Co first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and has held it in 17 quarters since.
  • D.E. Shaw & Co's Cardio Diagnostics Holdings Inc Warrant position peaked at $25.1K in Q1 2023.
  • 7 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.